A nurse is educating a group of nursing students about psychotherapeutic interventions for bipolar disorder. Select all the psychotherapeutic interventions that are commonly used for managing bipolar disorder.

Choice B rationale:

Evaluating the effectiveness of interventions is the primary goal of the nursing process during the implementation phase for a patient with bipolar disorder. Bipolar disorder is a chronic condition that requires ongoing management, and interventions are implemented to address both manic and depressive symptoms. By evaluating the effectiveness of interventions, the nurse can determine if the patient's symptoms are improving, worsening, or remaining stable. This information guides further adjustments to the care plan, ensuring that the patient receives the most appropriate and beneficial treatment.

Choice A rationale:

Collecting data about the patient's physical status is an important aspect of the assessment phase, not the implementation phase, of the nursing process. While physical status assessment informs the development of the care plan, the primary focus of implementation is to put the planned interventions into action and evaluate their outcomes.

Choice C rationale:

Planning evidence-based interventions for the patient is a crucial step in the planning phase of the nursing process. During this phase, the nurse identifies interventions that are tailored to the patient's specific needs and based on evidence-based practice. Once the planning is complete, the nurse moves on to implementing the interventions and subsequently evaluating their effectiveness.

Choice D rationale:

Administering pharmacological treatments is an action that falls within the implementation phase of the nursing process. However, it is not the primary goal of this phase for a patient with bipolar disorder. While pharmacological treatments may be part of the interventions, the primary focus is on evaluating the outcomes of these interventions to ensure the patient's symptoms are being effectively managed.

.

Choice A rationale:

Benzodiazepines can cause weight gain and increased appetite. Rationale: This statement is incorrect. Benzodiazepines are not typically associated with weight gain and increased appetite. Weight gain is more commonly associated with certain other psychotropic medications like some antipsychotics and mood stabilizers. Benzodiazepines primarily affect the central nervous system and are known for their sedative and anxiolytic properties rather than influencing appetite.

Choice B rationale:

Benzodiazepines are used to enhance the effects of dopamine in the brain. Rationale: This statement is incorrect. Benzodiazepines do not enhance the effects of dopamine in the brain. They work by enhancing the inhibitory effects of the neurotransmitter gamma-aminobutyric acid (GABA), which leads to sedative and calming effects. Dopamine is a separate neurotransmitter associated with reward, motivation, and movement control, and benzodiazepines do not directly influence its effects.

Choice C rationale:

Benzodiazepines are commonly prescribed as mood stabilizers. Rationale: This statement is incorrect. Benzodiazepines are not commonly prescribed as mood stabilizers. Mood stabilizers are a class of medications used to manage mood disorders like bipolar disorder. While benzodiazepines might be used in certain cases to manage anxiety or agitation associated with bipolar disorder, they are not considered primary mood stabilizers. Mood stabilizers like lithium, anticonvulsants (e.g., valproate, carbamazepine), and certain atypical antipsychotics are more commonly used for this purpose.

Choice D rationale:

Benzodiazepines may lead to cognitive impairment and dependence. Rationale: This statement is correct. Benzodiazepines are associated with potential cognitive impairment and the risk of dependence. These medications have sedative effects that can impact cognitive function, including memory and attention. Prolonged use of benzodiazepines can lead to physical and psychological dependence, making it important for healthcare providers to carefully assess and monitor their use in patients, particularly those with bipolar disorder.

.